Panel on Personal Genomic Testing (5/19/09)
Linda Avey, Co-founder, 23andMe
Daniel Ballon, Fellow, Technology Studies, Pacific Research Institute
David Magnus, Associate Professor, Stanford University School of Medicine
Mark Gerstein, Albert Williams Professor of Biomedical Informatics, Molecular Biophysics & Biochemistry, Computer Science, Yale University
Janet Rae-Dupree, Technology and Science Writer, Unboxed Media; Senior Editor, U.S. News & World Report - Moderator
Personal genomic testing (the analysis of the DNA of individuals) is now available for less than $400. The consequences of personal genetic testing are often debated, with advocates arguing that genetic data can lead to improved health care and critics warning that consumers may be unduly worried upon learning results. California regulations impose conditions on firms providing personal genomic testing. This symposium will examine genomic testing’s technology, its ramifications, government regulation of the industry, and whether individuals should have their genome analyzed.
This program was recorded in front of a live audience at the Commonwealth Club of California on May 19, 2009.